Cooper Financial Group Exelixis, Inc. Transaction History
Cooper Financial Group
- $731 Million
- Q1 2025
A detailed history of Cooper Financial Group transactions in Exelixis, Inc. stock. As of the latest transaction made, Cooper Financial Group holds 21,933 shares of EXEL stock, worth $956,717. This represents 0.11% of its overall portfolio holdings.
Number of Shares
21,933
Previous 21,377
2.6%
Holding current value
$956,717
Previous $711,000
13.78%
% of portfolio
0.11%
Previous 0.09%
Shares
13 transactions
Others Institutions Holding EXEL
# of Institutions
613Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.46 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.25 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$983 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$647 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$514 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...